Form 4 for JANX Janux Therapeutics, Inc.
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001415889-25-007104 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $4.21 | +3,334 | 85.5K | +4% | +$14.0K |
| DM | 2025-03-05 | 2025-03-03 | JANX | Meyer Andrew Hollman | Chief Business Off | S - Sale+OE | $32.14 | -3,334 | 83.0K | -4% | -$107.2K |
| D | 2025-03-05 | 2025-03-03 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $0.00 | -3,334 | 94.0K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | M | A | 3,334 | $4.21 | 85,473 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-03 | S | D | 901 | $32.85 | 82,139 | D | — | — | (F3) The weighted average sale price for the transaction reported was $32.8509 and the range of prices were between $32.53 and $33.15. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Common | Common Stock | 2025-03-03 | S | D | 2,433 | $31.88 | 83,040 | D | — | — | (F2) The weighted average sale price for the transaction reported was $31.8848 and the range of prices were between $31.50 and $32.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 4 | Derivative | Stock Option (right to buy) | 2025-03-03 | M | D | 3,334 | $0.00 | 93,999 | D | $4.21 · — to 2031-03-09 | 3,334 Common Stock | (F4) Immediately exercisable. |